Stock AMBS AMARANTUS BIOSCIENCE HOLDINGS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders Amarantus Bioscience Holdings Inc OTC Bulletin Board

Equities

AMBS

US02300U1060

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Amarantus Bioscience Holdings Inc
2022 Sector Update: Financial Stocks Still Adding to Wednesday Declines MT
2020 Todos Medical Ltd. (OTCPK:TOMD.F) completed the acquisition of remaining 80.01% stake in Breakthrough Diagnostics Inc. from Amarantus BioScience Holdings, Inc. CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Amarantus Bioscience Holdings, Inc. Names Michael T. Ropacki as Chief Medical Advisor to Alzheimer's Blood Diagnostic LymPro Test Program
CI
Amarantus BioScience Holdings, Inc. Announces Executive Changes
CI
Amarantus Bioscience Holdings, Inc Announces Resignation of Robert H. Trapp and Ronald Wei Resigned as Members of the Board of Directors
CI
Amarantus BioScience Holdings, Inc. Names Four New Appointees to Board of Directors and Interim-CFO
CI
Amarantus Announces Demise of Dr. Joseph Rubinfeld, Independent Director
CI
Amarantus Bioscience Holdings, Inc Announces Resignation of Robert Farrell as Chief Financial Officer
CI
Amarantus Bioscience Holdings, Inc Appoints Ravi Kiron as Sr. Vice President of Business Development
CI
Amarantus BioScience Holdings, Inc. Appoints Brian E. Harvey to its Strategic Advisory Board
CI
Amarantus Bioscience Holdings, Inc Announces Resignation of David Lowe as a Member of the Board of Directors
CI
Amarantus Bioscience Holdings, Inc Appoints Curtis Scribner as Sr. Vice President of Regulatory Affairs
CI
Amarantus Bioscience Holdings, Inc Announces Resignation of Iain G. Ross as Member of the Board of Directors
CI
Amarantus Bioscience Holdings, Inc will Change its Name to Amarantus Bioscience, Inc
CI
Amarantus BioScience Holdings Establishes Alzheimer's Disease Diagnostics Scientific Advisory Board
CI
Amarantus Bioscience Holdings, Inc. Appoints Elise Brownell as Senior Vice President of Operations and Project Management
CI
Amarantus Appoints Joseph Rubinfeld to its Board of Directors
CI
Amarantus Bioscience Holdings, Inc Appoints Iain Ross to Board of Directors
CI
Amarantus Bioscience Holdings, Inc Appoints Donald D. Huffman to the Board of Directors to Chair the Newly-Formed Audit Committee
CI
Amarantus Bioscience Holdings Establishes Office in Geneva, Switzerland; Appoints Mark Wakefield as Head of Clinical Development Across Amarantus' Diagnostic and Therapeutic Divisions
CI
Amarantus Bioscience Holdings, Inc. Appoints Dr. Charlotte Keywood Chief Medical Officer of its Therapeutics Division
CI
Amarantus Appoints Robert Farrell as Chief Financial Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AMBS Stock
  4. AMBS Stock
  5. News Amarantus Bioscience Holdings Inc
  6. Insiders